英文别名 |
VALDECOXIB;4-(5-METHYL-3-PHENYL-4-ISOXAZOLYL)BENZENESULFONAMIDE;AKOS 92130;BEXTRA;BEXTRA(VALDECOXIB);Bextra, 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenefulfonamide;4-(5-methyl-3-phenyl-oxazol-4-yl)benzenesulfonamide;Bextra, 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide;4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide;4-(5-methyl-3-phenyl-4-isoxazolyl)-benzenesulfonamide;SC 65872;[14C]-Valdecoxib;4-(4-sulfamoylphenyl)-5-methyl-3-phenyl-isoxazole;4-(5-methyl-3-phenylisoxazol-4-yl)benzensulfonamide;4-[5-methyl-3-phenylisoxazol-4-yl ] benzenesulfonamide;Kudeq;Valdecoxib(R);Valdyn;4-(5-Methyl-3-phenyl-4-isooxazolyl)benzenesulfonamide;Valz;Valus;Valecoxib;Parecoxib Impurity 4;Valdecoxib Solution, 100ppm;4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide;Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-;p-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide;LNPDTQAFDNKSHK-UHFFFAOYSA-N;4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonamide;COX;NCGC00095129-0;SPBio_000435;DTXCID4024226;C21552;BRD-K12994359-001-14-3;FT-0675755;SR-01000759421-4;CHEBI:63634;cid_119607;SCHEMBL3356;BRD-K12994359-001-02-8;Spectrum_001747;Spectrum5_001476;HMS1922J21;J-513600;CCG-39589;M01AH03;HMS3885O20;NSC-759846;Valdecoxib [USAN:INN:BAN];s4049;MRF-0000216;MLS001424105;NCGC00095129-01;BSPBio_002721;Spectrum4_001129;UNM-0000305814;BCP02419;Spectrum2_000508;YM-974;NCGC00095129-06;SPECTRUM1504302;VLX;Spectrum3_001001;FT-0631199;VALDECOXIB [MART.];ND-0214;Valdecoxib [USAN];valdecoxibum;MLS001165699;Tox21_111438;HSDB 7302;HMS2051P07;CS-1674;KBio3_001941;SR-01000759421;DB00580;4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide;KBio2_004795;CHEMBL865;SC-65872;HMS3372D12;Q347613;MLS000759433;181695-72-7;VALDECOXIB [WHO-DD];SB19519;Tox21_111438_1;NSC 759846;AKOS000280920;2919279Q3W;InChI=1/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20;D02709;2aw1;AB00639996_10;Valdecoxib, analytical reference material;Valdecoxib (USAN/INN);MFCD00950568;VALDECOXIB [INN];HMS2232P23;KBio2_002227;KBio2_007363;DTXSID6044226;HMS3652I04;AMY31078;HMS3715L18;4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide;Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)- (9CI);GTPL2894;AC-120;NC00184;VALDECOXIB [HSDB];NCGC00095129-02;J-011613;KBioGR_001617;4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide;AB00639996-08;SMR000466327;NS00009831;EX-A241;VALDECOXIB [ORANGE BOOK];CAS-181695-72-7;KBioSS_002227;NSC759846;EN300-7393031;BDBM13063;SW197564-2;A812629;VALDECOXIB [VANDF];VALDECOXIB [EMA EPAR];4-(Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide;Valdecoxib, >=98% (HPLC);Pharmakon1600-01504302;VALDECOXIB [MI];4-[5-methyl-3-phenylisoxazol-4-yl]benzensulfonamide;MLS001195631;UNII-2919279Q3W;VALDECOXIB (MART.);NCGC00095129-03;Valdecoxib-13C2, 15N;HMS3393P07;HY-15762;BRD-K12994359-001-18-4;DB-044435 |